EElligint Health provides a data analytics platform designed for the value-based care (VBC) market. It targets payers, Accountable Care Organizations (ACOs), and mid-market VBC providers, offering a SaaS-based solution combined with expert guidance. The platform integrates advanced analytics, real-time insights, and predictive modeling to help clients reduce operational costs through optimized resource allocation and to improve health outcomes via automated workflows and risk stratification. It also simplifies data integration and regulatory navigation, positioning itself as a turnkey solution enhanced by an industry advisory board that guides product development and strategy. The company’s goal is to help healthcare organizations perform better within the VBC framework by shortening time to value and enabling data-driven decision making.
Work here?Claim your company
Industries
Company Size
51-200
Company Stage
Seed
Total Funding
$3.2M
Headquarters
Edison, NJ
Founded
2025
See people who can refer or advise you
Help us improve and share your feedback! Did you find this helpful?
Total Funding
$3.2M
Meets
Industry Average
Funded Over
1 Rounds
Industry standards
Elligint Health has adopted AWS HealthLake as the core FHIR data store inside its Helios platform. The move helps health plans meet CMS-0057-F rules on electronic prior authorisation and data exchange. AWS HealthLake is a fully managed, HIPAA-eligible FHIR R4 service from Amazon Web Services (AWS). It builds on Elligint's existing use of AWS cloud infrastructure. Within Helios, HealthLake acts as a live FHIR copy of each client's data, refreshed in minutes. Members, providers, and other payers access it through Patient Access, Provider Access, Payer-to-Payer, and Prior Authorization APIs. Prior authorisation decisions appear in minutes, well within the rule's one-business-day limit. "Embedding AWS HealthLake gives our clients a direct path to the FHIR foundation that today's interoperability requirements demand," said chief executive officer Chris Caramanico.
New Jersey Economic Development Authority invests $16.5M to support 8 startups. ROI-NJ Staff(Trenton) October 19, 2026 Since February, the New Jersey Economic Development Authority (NJEDA) has approved a total of $16.5 million to support eight cutting-edge businesses through the New Jersey Innovation Evergreen Fund (NJIEF). The startups are working on pushing forward new technologies in various sectors, including health care, biotechnology, and life sciences. NJIEF increases access to strategic resources and venture capital in New Jersey, with the state as an equity investor in early-stage companies and deploying up to $600 million alongside venture capital firms. "The NJIEF's success is measured not just in dollars invested, but in the transformative impact it has had on New Jersey businesses," said NJEDA Chief Executive Officer Evan Weiss. "This cutting-edge initiative fuels innovation, creates jobs, and positions our state as a global center for technological discovery. Through strategic partnerships and targeted investments, Governor Mikie Sherrill and the NJEDA are helping the next generation of companies thrive, reinforcing New Jersey's reputation as a leader in innovation and opportunity." The following companies received investment funding through the NJIEF: * Princeton Critical Minerals Inc. (PCM)- Newark PCM, which emerged from Princeton University, has developed a technology for boosting mineral production from evaporation ponds, which could revolutionize the conventional approach to critical minerals extraction. The company provides an integrated suite of products, all dedicated to bridging the lithium supply-demand gap through efficient, scalable, and sustainable extraction methods. PCM was approved for an NJIEF investment of $4 million by matching SOSV, a global multi-stage venture capital firm based in Princeton. * Cranium AI Inc. - Short Hills Founded in 2023 as a spin-out from KPMG's startup incubator, Cranium AI provides organizations with tools to map, monitor, test, and govern their machine learning and generative artificial intelligence systems against adversarial threats and compliance risks, including systems from third-party vendors. Cranium AI client roster includes Johnson & Johnson, JP Morgan Chase, KPMG, FIS, and Pfizer. Cranium AI was approved for an NJIEF investment of $5 million through matching SYN Ventures, a specialized cybersecurity-focused venture capital firm. * Urologic Health - Jersey City Urologic Health is a medical device company developing the first fully non-invasive urodynamic diagnostic system for bladder function assessment. Urologic Health is addressing a significant problem in urology diagnostics, where the current test requires catheterization. Urologic's system eliminates the need for catheters entirely while providing the diagnostic data necessary for both men and women. Urologic was approved for an NJIEF investment of $1.25 million by matching Edge Medical Ventures, an early-stage investment firm with offices in Jersey City and Israel. * Elligint Health Inc. - Edison Elligint Health provides a health care management platform for health insurance companies, specifically focusing on care and disease management for high-risk patients. The company's main product is Helios, a cloud-based platform that provides care managers with a single system to access patient information and automatically prioritizes tasks and generates care plans, helping increase productivity. Elligint Health was approved for an NJIEF investment of $1.5 million by matching HLM Investment Partners, a venture firm focused on investments in health care services, health care technology, and health care innovation companies. * TangGene Inc. - New Brunswick TangGene is a biotechnology company developing an injectable drug to cure autoimmune diseases that currently have no cure, starting with Multiple Sclerosis. The company's technology helps retrain the immune system to target the cells causing the disease while leaving the rest of the immune system intact. TangGene was approved for an NJIEF investment of up to $1.5 million through an application submitted by Oak BioCapital, a venture firm focused on investments in life sciences and biotech companies. * AstraNu Inc. - Murray Hill Founded in 2025, AstraNu is a Nokia Bell Labs spin-out developing low-cost medical imaging technology for eye care and diagnostics. AstraNu's strategy focuses on commercializing an integrated Optical Coherence Tomography "engine module" that medical device manufacturers can plug directly into their products. This module combines all the necessary parts into a single computer chip that is 10x smaller and cheaper than traditional components. AstraNu was approved for an NJIEF investment of up to $1.5 million by matching Celesta Capital, a venture capital firm that focuses on investing in deep tech, data infrastructure, next-generation enterprise applications, and services. * ChorusRx - Mount Laurel ChorusRx (formally GalenusCare) is a next-generation pharmacy and medication-risk management company purpose-built for high-risk, high-acuity populations, such as hospice and chronic-care patients. At the core of its offering is APPRAISE, an exclusive, AI-enabled medication-optimization platform leveraging pharmacogenics and regimen-level risk scoring. ChorusRx was approved for an NJIEF investment of almost $1 million through by matching Rittenhouse Ventures, which focuses on early-growth B2B software investments, and aims to provide venture capital returns with a risk profile similar to private equity or growth equity funds. * Sena Health - Mickleton Sena Health is an AI-enabled healthcare access and care coordination company that blends contextual AI agents with clinically trained human coordinators to reduce administrative burden for medical groups, health systems, and employers. It replaces fragmented call centers, scheduling tools, and back-office processes with a single operating foundation. Its flagship offering - the Access Command Center - provides patient scheduling, triage, care navigation, referral management, revenue cycle operations, and high acuity care coordination. Sena Health was approved for an NJIEF investment of $750,000 by matching Rittenhouse Ventures, making it the third investment made by this venture capital group under the Evergreen program over the recent two years.
Elligint Health & Sagility announce alliance to deliver turnkey care & utilization management solutions for Health Plans. Distributed by EIN Presswire Partnership Combines the Helios(R) Platform with Sagility's Healthcare Operational Expertise to Offer Health Plans a Complete End-to-End CM/UM Solution EDISON, NJ, UNITED STATES, October 14, 2026 /EINPresswire.com/ - Elligint Health and Sagility today announced a strategic alliance designed to give health plans a fully integrated, turnkey approach to care and utilization management (CM/UM). By combining the clinical workflow intelligence of Helios(R) by Elligint Health with Sagility's deep healthcare operational expertise, the two organizations will offer payers a single, cohesive solution that addresses both the technology and the operational infrastructure required to run high-performing CM/UM programs at scale. Health plans today face a convergence of pressures: tightening margins, mounting regulatory requirements, workforce constraints, and rising expectations for measurable outcomes. The Elligint Health-Sagility alliance is designed to address that reality directly. Through the partnership, shared clients gain access to Sagility's Business Process as a Service capabilities - including clinically informed pre-built workflows, Sagility's gold-standard implementation model, purpose-built training and dedicated support, and if needed, end-to-end CM/UM operational staffing and program management - giving health plans the option to fully outsource their Helios-powered CM/UM operations rather than building or maintaining internal teams. The alliance reflects a shared recognition that successful CM/UM transformation requires more than modern software. It requires the operational depth, implementation discipline, and domain expertise to ensure that platform capabilities translate into measurable performance. Together, Elligint Health and Sagility offer health plans a path from deployment to outcomes - with the processes and partnerships already in place to get there. "Health plans need more than a platform - they need a partner that can help them operationalize it. Our alliance with Elligint Health brings together two organizations that share a commitment to making care and utilization management work in the real world. By combining Helios' clinical workflow intelligence with Sagility's operational services and implementation expertise, we're giving health plans a faster, more confident path to outcomes." said Bill Bottomly, Vice President, Partnerships, Sagility. Chris Caramanico, CEO of Elligint Health, added: "This alliance couples people and process with technology for maximum impact and operational scale in a constantly evolving market. Health plans need the right platform and the right operational partner to support optimal performance. Sagility brings significant clinical operations expertise and a global operational infrastructure that is genuinely complementary to what Helios delivers to payers. Together, we can offer health plans something the market hasn't had before: a fully integrated, turnkey CM/UM solution built for the complexity of today's payer environment." About Elligint Health Founded in 2024, Elligint Health is a mission-driven organization dedicated to making healthcare more proactive, connected, and intelligent. Elligint Health partners with the nation's most innovative payers and providers to turn data into actionable strategies. By aligning all stakeholders - members, providers, and payers - Elligint Health helps organizations navigate complexity with clarity, creating a healthcare ecosystem that is smarter, more sustainable, and centered on whole-person care. Elligint Health's comprehensive solution provides the performance engine for modern payer and provider organizations - built on an ecosystem of smarter tech, actionable insights, and expanded capabilities. Elligint Health brings together Helios(R) for CM and UM, Advanced Analytics for prediction and performance, and a Helios Partner Ecosystem to extend and complement the capabilities of our single-platform solution. With more than 13 million lives managed across all 50 states, Elligint Health helps payer and provider teams transform operations, anticipate change, and accelerate smarter care. About Sagility Sagility is an AI-led, US healthcare-focused business operations solutions and services company that supports payers, providers, and their partners in delivering best-in-class operations, enhancing member and provider experiences, and improving the quality of care, all while ensuring cost-effective financial and clinical outcomes. With more than 25 years of exclusive focus in healthcare, Sagility's dedicated experts address complex healthcare challenges through deep domain expertise and technology innovations. Serving over 80 healthcare clients, including 7 of the top 10 US health plans in the US, Sagility delivers end-to-end operational transformation at scale through a model built on accountability, transparency, and measurable outcomes. The company delivers these services through its skilled talent pool of nearly 50,000 professionals across five global service delivery centers located in the US, India, the Philippines, Jamaica, and Colombia. Legal Disclaimer: EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above. Media gallery Information contained on this page is provided by an independent third-party content provider. XPRMedia and this Site make no warranties or representations in connection therewith. If you are affiliated with this page and would like it removed please contact [email protected]
Elligint Health and Sagility have formed an alliance to give health plans a turnkey approach to care and utilization management (CM/UM). The deal pairs Elligint's Helios® platform with Sagility's healthcare operations expertise. Shared clients can use Sagility's Business Process as a Service capabilities, including pre-built workflows, implementation, training, and support. Health plans can also fully outsource their Helios-powered CM/UM operations, including staffing and program management, instead of running internal teams. "Health plans need more than a platform — they need a partner that can help them operationalize it," said Bill Bottomly, vice president of partnerships at Sagility. Elligint Health, founded in 2024, manages more than 13 million lives across all 50 US states. Sagility serves over 80 healthcare clients and employs nearly 50,000 people.
Elligint Health & Laguna Health announce strategic partnership to strengthen ai-driven care mgmt. for Payers & members. Distributed by EIN Presswire Partnership pairs Helios(R) by Elligint Health with Laguna Health's conversational AI suite to help health plans extend care team capacity and improve outcomes. EDISON, NJ, UNITED STATES, October 6, 2026 /EINPresswire.com/ - Elligint Health, provider of the Helios(R) Intelligence Platform serving health plans and value-based care organizations, today announced a commercial partnership with Laguna Health, a conversational AI company for payer case management. The collaboration is designed to give Elligint Health's payer clients expanded tools to support care teams and improve outcomes for the members they serve. The partnership brings together two complementary capabilities: Elligint Health's care management, utilization management, analytics, and population health infrastructure - which today supports care coordination across millions of covered lives - with Laguna Health's conversational AI, which helps care teams manage higher caseloads while maintaining consistent, high-quality member interactions during high-risk moments. What This Means for Payers Health plans working with Elligint Health will gain access to Laguna Health's conversational AI tools as part of their case management strategy, with the goal of helping care teams: - Expand capacity to support more members without proportional increases in headcount - Reduce the administrative burden on care teams so more time can be spent on complex, high-touch cases supporting care teams to work at the top of their license - Maintain consistent outreach and follow-up at the moments in a member's care that matter most, when engagement has the greatest impact - Surface real-time insights from member conversations that help care teams identify who needs additional support before problems escalate - Review 100% of member interactions for quality and compliance rather than a manual sample - Support caseload optimization and quality Moving from Sampling towards Quality in Every Interaction Elligint Health's payer clients will also gain access to Laguna Insight, which brings quality management, audit, and compliance review to every member interaction rather than a sampled subset. Health plans today typically review a small fraction of calls by hand, which leaves the majority of the member experience unmeasured and most coaching opportunities undiscovered. Laguna Insight evaluates interactions against a plan's own quality and compliance criteria, including the standards that drive regulatory and accreditation review, and delivers the results to supervisors and quality teams with the supporting evidence attached. The same review applies to agentic interactions, giving plans one oversight framework as AI takes on more member-facing work Published and Validated Results Laguna Health's impact is documented in published, customer-reviewed case studies and in peer-reviewed research. In a published case study at a multi-state health plan, care teams recorded: - 66% reduction in post-call documentation time - 99% accuracy in AI-generated clinical content - 96% of care managers surveyed reported they are more efficient with Laguna - 96 additional member enrollments per care manager per year Separately published case studies document a 26% efficiency improvement at a risk-bearing provider organization on a four-week implementation, and a 27% gain in call-preparation efficiency at a national payer services organization. Laguna Health's clinical approach has been evaluated with results published in peer-reviewed journals. What This Means for Members Ultimately, the partnership is designed to benefit the members payers serve - particularly those navigating the vulnerable periods in their care journeys. By combining Elligint Health's population health and risk insights with Laguna Health's conversational AI tools, payers will be better positioned to: - Ensure more members receive timely, consistent follow-ups by easing administrative burden - Receive support that adapts to their individual needs and risk level, rather than one-size-fits-all outreach - Experience fewer gaps in their care journeys - Benefit from care teams who have more visibility and can be proactive According to Chris Caramanico, CEO of Elligint Health, "Payers are being asked to do more for their members with fewer resources, and care teams feel that pressure every day. This partnership with Laguna Health lets us bring conversational AI directly into the care management workflows our clients already rely on, so care managers can support more members with consistent and higher quality without losing the personal connection that makes care management effective in the first place." Yoni Shtein, CEO of Laguna Health, noted that, "We started Laguna because care teams don't have the bandwidth to reach everyone who needs them. Partnering with Elligint Health means our conversational AI can now support care teams across a much broader base of health plans and members, right where those teams are already doing their work." About Elligint Health Founded in 2024, Elligint Health is a mission-driven organization dedicated to making healthcare more proactive, connected, and intelligent. Elligint Health partners with the nation's most innovative payers and providers to turn data into actionable strategies. By aligning all stakeholders - members, providers, and payers - Elligint Health helps organizations navigate complexity with clarity, creating a healthcare ecosystem that is smarter, more sustainable, and centered on whole-person care. Elligint Health's comprehensive solution provides the performance engine for modern payer and provider organizations - built on an ecosystem of smarter tech, actionable insights, and expanded capabilities. Elligint Health brings together Helios(R) for CM and UM, Advanced Analytics for prediction and performance, and Helios Partner Ecosystem to extend and complement the capabilities of our single-platform solution. With more than 13 million lives managed across all 50 states, Elligint Health helps payer and provider teams transform operations, anticipate change, and accelerate smarter care. About Laguna Health Laguna Health offers conversational AI for care management teams. Its products, Laguna Companion, Laguna Insight, and LISA, help care teams increase capacity, hold quality consistent across every member interaction, and increase quality management across both human and agentic member interactions. Founded in 2020, Laguna Insight was named to TIME's Best Inventions of 2024, CB Insights Digital Health 50, and DHNY 100 for three consecutive years. Published customer case studies and peer-reviewed research are available at lagunahealth.com. Laguna Health is SOC 2 Type II attested and ISO 27001 certified. Legal Disclaimer: EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above. Media gallery Information contained on this page is provided by an independent third-party content provider. XPRMedia and this Site make no warranties or representations in connection therewith. If you are affiliated with this page and would like it removed please contact [email protected]
Find jobs on Simplify and start your career today
Don't see your dream role? Check out thousands of other roles on Simplify.Browse all jobs
Industries
Company Size
51-200
Company Stage
Seed
Total Funding
$3.2M
Headquarters
Edison, NJ
Founded
2025
Find jobs on Simplify and start your career today
Don't see your dream role? Check out thousands of other roles on Simplify.Browse all jobs